We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · November 08, 2020

Effect of Vericiguat on Quality of Life in Patients With HFpEF

JAMA: The Journal of the American Medical Association


Additional Info

JAMA: The Journal of the American Medical Association
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial
JAMA 2020 Oct 20;324(15)1512-1521, PW Armstrong, CSP Lam, KJ Anstrom, J Ezekowitz, AF Hernandez, CM O'Connor, B Pieske, P Ponikowski, SJ Shah, SD Solomon, AA Voors, L She, V Vlajnic, F Carvalho, L Bamber, RO Blaustein, L Roessig, J Butler

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading